重新回顾上之前的情况
Shannon C Miller1, Sharon Levy, Andrew J Saxon
1From the Mental Health Service, VA Medical Center, Dayton/Middletown, OH (SCM); Departments of Psychiatry & Population and Public Health Sciences, Boonshoft School of Medicine, Wright State University, Dayton, OH (SCM); Division of Addiction Medicine, Boston Children's Hospital, Boston, MA (SL); Department of Pediatrics, Harvard Medical School, Boston, MA (SL); Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA (AJS); Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA (AJS); Program in Addiction Medicine, Yale School of Medicine, New Haven, CT (JMT); Division of Addiction Psychiatry, Department of Psychiatry and Behavioral Health, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY (RNR); Department of Medicine, Harvard Medical School, Boston, MA (SW); Program in Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA (SW); and Friends Research Institute, Baltimore, MD (FV).
对有害物质使用的早期干预至关重要. 研究人员认为",不健康的物质使用"是一个比"先前成"更好的术语来识别需要支持的个人,但存在障碍.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 药物使用障碍 药物使用障碍
背景情况:
- 国家药物滥用研究所和国家酒精滥用和酒研究所建议对有害物质使用的早期识别和干预.
- 术语"前成"已被建议作为早期干预目标的诊断标签.
研究的目的:
- 评估拟议的术语"前成"用于早期干预物质使用.
- 建议"不健康的物质使用"作为更合适的描述词.
- 确定实施这种新干预模式的潜在障碍.
主要方法:
- 对拟议的术语和干预策略的评论和审查.
- 分析诊断标签对早期干预的影响.
主要成果:
- "不健康的物质使用"被认为是一个比"先前成"更合适的描述词.
- 确定了几种可能阻碍这种新范式影响的潜在障碍.
结论:
- 采用"不健康物质使用"可能会促进更早,更有效的干预措施.
- 解决已识别的障碍对于成功实施有害物质使用早期干预战略至关重要.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
Desensitization and Tachyphylaxis
Drug Dependence
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...


